Grégoire Leclair
- Biomaterials top 5%
- Pharmaceutical Science top 2%
- Molecular Biology
- Biomedical Engineering
- Molecular Medicine top 5%
- Co-authors
- Patrice HildgenJean‐Christophe LerouxAnand GuptaGaëlle RoullinMichel MeunierJean‐Philippe SylvestreJean‐Michel RabanelMartin Jutras
- Topics
- Pharmaceutical studies and practices (18 papers)Safe Handling of Antineoplastic Drugs (9 papers)Drug Solubulity and Delivery Systems (7 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEPEDIATRICS
- Partner nations
- CanadaSwitzerlandUnited Kingdom
In The Last Decade
Grégoire Leclair
63 papers receiving 930 citations
Peers
Comparison fields: 5 of 122
- Biomaterials 251
- Pharmaceutical Science 237
- Molecular Biology 204
- Biomedical Engineering 173
- Molecular Medicine 124
Countries citing papers authored by Grégoire Leclair
This map shows the geographic impact of Grégoire Leclair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grégoire Leclair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grégoire Leclair more than expected).
Fields of papers citing papers by Grégoire Leclair
This network shows the impact of papers produced by Grégoire Leclair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grégoire Leclair. The network helps show where Grégoire Leclair may publish in the future.
Co-authorship network of co-authors of Grégoire Leclair
This figure shows the co-authorship network connecting the top 25 collaborators of Grégoire Leclair. A scholar is included among the top collaborators of Grégoire Leclair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grégoire Leclair. Grégoire Leclair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 14 | |
| 7 | 10 | |
| 8 | 15 | |
| 9 | 5 | |
| 10 | 3 | |
| 11 | 4 | |
| 12 | 3 | |
| 13 | 6 | |
| 14 | 2 | |
| 15 | 3 | |
| 16 | 10 | |
| 17 | 1 | |
| 18 | 0 | |
| 19 | 10 | |
| 20 | 15 |
About Grégoire Leclair
Grégoire Leclair is a scholar working on Occupational Therapy, Pharmaceutical Science and Pediatrics, Perinatology and Child Health, having authored 70 papers that have together received 949 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (18 papers), Safe Handling of Antineoplastic Drugs (9 papers) and Drug Solubulity and Delivery Systems (7 papers). The work is most often cited by research in Pharmaceutical Science (237 citations), Molecular Medicine (124 citations) and Biomaterials (251 citations). Grégoire Leclair has collaborated with scholars based in Canada, Switzerland and United Kingdom. Frequent co-authors include Patrice Hildgen, Jean‐Christophe Leroux, Anand Gupta, Gaëlle Roullin, Michel Meunier, Jean‐Philippe Sylvestre, Jean‐Michel Rabanel, Martin Jutras, Nicolas Bertrand and Alexandra Fürtös. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.